Candida auris-the growing menace to global health

Mycoses
Shabir A Lone, Aijaz Ahmad

Abstract

A paradigm shift of candidiasis from Candida albicans to non-albicans Candida species has fundamentally increased with the advent of C. auris. C. auris, despite being a newly emerged multidrug-resistant fungal pathogen, is associated with severe invasive infections and outbreaks with high mortality rates. Initially reported from Japan in 2009, C. auris have now been found in different countries on all the continents except Antarctica. Due to its capability of nosocomial transmission and forming adherent biofilms on clinically important substrates, a high number of related hospital outbreaks have been reported worldwide. As C. auris is a multidrug-resistant pathogen and is prone to misidentification by available conventional methods, it becomes difficult to detect and manage C. auris infection and also limits the therapeutic options against this deadly pathogen. The emergence of multidrug-resistant C. auris advocates and amplifies the vigilance of early diagnosis and appropriate treatment of fungal infections. In this review, we discussed the nine-year-old history of C. auris-its trends in global emergence, epidemiological relatedness, isolation, mortality, associated risk factors, virulence factors, drug resistance and suscepti...Continue Reading

References

Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mi-Na KimDong Wook Ryang
Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
Dec 17, 2014·Intensive Care Medicine·Arunaloke ChakrabartiDeepak Mendiratta
Apr 18, 2015·Journal of Infection in Developing Countries·Dharmendra KumarRagini Tilak
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Sep 9, 2015·BMC Genomics·Sharanya ChatterjeeUtpal S Tatu
Nov 10, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Anupam PrakashAnuradha Chowdhary
Apr 14, 2016·Antimicrobial Resistance and Infection Control·John M Boyce
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Sep 17, 2016·The Journal of Hospital Infection·A ChowdharyJ F Meis
Oct 8, 2016·Journal of Microbiology and Biotechnology·Tae-Hyoung KimMi-Kyung Lee
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Nov 9, 2016·BMJ : British Medical Journal·Michael McCarthy
Nov 25, 2016·Journal of Clinical Microbiology·Masako MizusawaSean X Zhang
Dec 17, 2016·Emerging Infectious Diseases·Soraya E Morales-LópezJosé Y Rodríguez
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cornelius J Clancy, M Hong Nguyen
Dec 29, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S VallabhaneniT M Chiller
Jan 19, 2017·Emerging Infectious Diseases·Ronen Ben-AmiTalya Finn
Jan 19, 2017·Emerging Infectious Diseases·Leighann SherryRiina Rautemaa-Richardson
Jan 31, 2017·Revista iberoamericana de micología·Alba Cecilia Ruiz GaitánJavier Pemán
Feb 17, 2017·Medical Mycology·Andrew M BormanElizabeth M Johnson
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyAnup Ghosh
Mar 24, 2017·The American Journal of Nursing·Betsy Todd
Apr 6, 2017·Mycoses·Hyoung Il ChoiJun Seong Son
May 10, 2017·Antimicrobial Agents and Chemotherapy·Elizabeth L BerkowShawn R Lockhart
May 19, 2017·MMWR. Morbidity and Mortality Weekly Report·Sharon TsayBrendan R Jackson
May 19, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marwan M AzarVirginia M Pierce
May 26, 2017·Journal of Clinical Microbiology·Milena KordalewskaDavid S Perlin
Jun 6, 2017·The Journal of Infection·Turkiya Al-SiyabiBadriya Al'Adawi
Jun 7, 2017·Antimicrobial Agents and Chemotherapy·Alexander J LepakDavid R Andes
Jun 28, 2017·Infection and Drug Resistance·Smita Sarma, Shalini Upadhyay
Jul 8, 2017·Mycoses·Jalila MohsinAbdullah M S Al-Hatmi
Jul 12, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Christina T PiedrahitaCurtis J Donskey
Aug 8, 2017·Expert Review of Anti-infective Therapy·Bhagyashri D NavalkelePranatharthi Chandrasekar

❮ Previous
Next ❯

Citations

Jul 25, 2019·Journal of Fungi·Daniel Z P Friedman, Ilan S Schwartz
Oct 28, 2019·Journal of Fungi·Amal Al MaaniAbdullah M S Al-Hatmi
Oct 15, 2019·Journal of Medical Microbiology·Arunaloke Chakrabarti
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
May 19, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ahmed S SultanMary Ann Jabra-Rizk
Apr 17, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Amira ElBaradei
Jul 10, 2020·Pathogens and Disease·Taissa VilaMary Ann Jabra-Rizk
Jul 15, 2020·Antimicrobial Agents and Chemotherapy·Gina Wall, Jose L Lopez-Ribot
Aug 7, 2020·FEMS Yeast Research·Garima ShahiRajendra Prasad
Apr 21, 2020·Emerging Infectious Diseases·Kellie ArensmanJennifer Dela Pena
Sep 30, 2020·World Journal of Microbiology & Biotechnology·Ifeanyi Elibe Mba, Emeka Innocent Nweze
Jun 11, 2019·Emerging Microbes & Infections·Scott C RobertsBabafemi O Taiwo
Oct 22, 2020·Scientific Reports·Makoto SumiyoshiHiroshi Mukae
Dec 10, 2020·Scientific Reports·Patrick SchwarzEric Dannaoui
Oct 21, 2020·Antimicrobial Agents and Chemotherapy·Jian BingGuanghua Huang
Oct 14, 2020·Antimicrobial Agents and Chemotherapy·Hassan E EldesoukyMohamed N Seleem
Jan 12, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Hiram Villanueva-LozanoMichel F Martínez-Reséndez
Nov 20, 2020·Journal of Clinical Microbiology·Sourav DasAnup Ghosh
Jan 25, 2021·American Journal of Infection Control·Eric J EckboMarthe Charles
Feb 20, 2021·International Microbiology : the Official Journal of the Spanish Society for Microbiology·Mihrinur Yapıcıİlknur Dağ
Jan 20, 2020·International Journal of Antimicrobial Agents·A L BidaudE Dannaoui
Apr 14, 2021·Microbial Pathogenesis·Nahid AkhtarM Amin-Ul Mannan
May 20, 2021·Mycoses·João Nobrega de AlmeidaUNKNOWN Candida auris Brazilian Study Group
May 22, 2021·Infectious Disease Clinics of North America·Emma E SeagleTom M Chiller
Jun 5, 2021·Frontiers in Pharmacology·Brynn A HollingsworthLanyn P Taliaferro
Jul 3, 2021·International Journal of Molecular Sciences·Jonothan Rosario-ColonHong Xin
Aug 8, 2021·Infectious Disease Clinics of North America·Geeta Sood, Trish M Perl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.